(Q57138044)

English

A meta-analysis of randomized controlled trials comparing chemotherapy plus trastuzumab with chemotherapy alone in HER-2-positive advanced breast cancer

article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

0 references

0 references

1 reference

Europe PubMed Central

A meta-analysis of randomized controlled trials comparing chemotherapy plus trastuzumab with chemotherapy alone in HER-2-positive advanced breast cancer (English)

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Cun Liao

1

0 references

Fang Yin

2

0 references

Ping Huang

3

0 references

Yunfei Cao

4

0 references

Feng Gao

5

0 references

language of work or name

0 references

The Breast Journal

0 references

17

0 references

1

0 references

109-11

0 references

Randomized Phase II Trial of weekly paclitaxel alone versus trastuzumab plus weekly paclitaxel as first-line therapy of patients with Her-2 positive advanced breast cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2010.01034.X

21 January 2018

Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2010.01034.X

21 January 2018

Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2010.01034.X

21 January 2018

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2010.01034.X

21 January 2018

Cardiac dysfunction in the trastuzumab clinical trials experience

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2010.01034.X

21 January 2018

Identifiers

10.1111/J.1524-4741.2010.01034.X

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57138044&oldid=1997371795"